Microbial metabolites in health and disease: Navigating the unknown in search of function

Journal of Biological Chemistry

Volumn 292, Issue 21, 2017, Pages 8553-8559

  Martinez, Kristina B ^a   Leone, Vanessa ^a   Chang, Eugene B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; BIOMOLECULES; DISEASE CONTROL; METABOLITES; RNA;

FUNCTIONAL CHARACTERISTICS; FUNCTIONAL CHARACTERIZATION; INFLAMMATORY BOWEL DISEASE; IRRITABLE BOWEL SYNDROMES; MICROBIAL COMMUNITIES; MICROBIAL METABOLITES; NON-ALCOHOLIC FATTY LIVER DISEASE; TECHNOLOGICAL ADVANCES;

DISEASES;

RNA 16S; SHORT CHAIN FATTY ACID; TRYPTOPHAN DERIVATIVE; BACTERIAL RNA;

CARDIOVASCULAR DISEASE; CHRONIC DISEASE; HELICOBACTER PYLORI; HOST; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; METABOLIC DISORDER; METABOLITE; METABOLOMICS; METAGENOMICS; METATRANSCRIPTOMICS; MICROBIOME; NEUROLOGIC DISEASE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSCRIPTOMICS; ANIMAL; DIABETES MELLITUS; GENETICS; HOST PATHOGEN INTERACTION; IRRITABLE COLON; METABOLISM; MICROBIOLOGY; OBESITY;

ANIMALS; DIABETES MELLITUS; GASTROINTESTINAL MICROBIOME; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATORY BOWEL DISEASES; IRRITABLE BOWEL SYNDROME; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S;

EID: 85019711051     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R116.752899     Document Type: Review

References (58)

1. Donia, M. S., and Fischbach, M. A. (2015) Human microbiota. Small molecules from the human microbiota. Science 349, 1254766
2. Langille, M. G., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes, J. A., Clemente, J. C., Burkepile, D. E., Vega Thurber, R. L., Knight, R., Beiko, R. G., and Huttenhower, C. (2013) Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31, 814-821
3. Sharpton, T. J. (2014) An introduction to the analysis of shotgun metagenomic data. Front. Plant Sci. 5, 209
4. Abubucker, S., Segata, N., Goll, J., Schubert, A. M., Izard, J., Cantarel, B. L., Rodriguez-Mueller, B., Zucker, J., Thiagarajan, M., Henrissat, B., White, O., Kelley, S. T., Methe, B., Schloss, P. D., Gevers, D., et al. (2012) Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput. Biol. 8, e1002358
5. Meyer, F., Paarmann, D., D'Souza, M., Olson, R., Glass, E. M., Kubal, M., Paczian, T., Rodriguez, A., Stevens, R., Wilke, A., Wilkening, J., and Edwards, R. A. (2008) The metagenomics RAST server-a public resource for the automatic phylogenetic and functional analysis of metagenomes.BMC Bioinformatics 9, 386
6. Goll, J., Rusch, D. B., Tanenbaum, D. M., Thiagarajan, M., Li, K., Methe, B. A., and Yooseph, S. (2010) METAREP: JCVI metagenomics reports-an open source tool for high-performance comparative metagenomics. Bioinformatics 26, 2631-2632
7. Crusoe, M. R., Alameldin, H. F., Awad, S., Boucher, E., Caldwell, A., Cartwright, R., Charbonneau, A., Constantinides, B., Edvenson, G., Fay, S., Fenton, J., Fenzl, T., Fish, J., Garcia-Gutierrez, L., Garland, P., et al. (2015) The khmer software package: enabling efficient nucleotide sequence analysis. F1000Res. 4, 900
8. Eren, A. M., Esen, O.C., Quince, C., Vineis, J. H., Morrison, H. G., Sogin, M. L., and Delmont, T. O. (2015) Anvi'o: an advanced analysis and visualization platform for 'omics data. PeerJ. 3, e1319
9. Bashiardes, S., Zilberman-Schapira, G., and Elinav, E. (2016) Use of metatranscriptomics in microbiome research. Bioinform. Biol. Insights 10, 19-25
10. Coates, M. E. (1975) Gnotobiotic animals in research: their uses and limitations. Lab. Anim. 9, 275-282
11. Al-Asmakh, M., and Zadjali, F. (2015) Use of germ-free animal models in microbiota-related research. J. Microbiol. Biotechnol. 25, 1583-1588
12. Nicklas, W., Keubler, L., and Bleich, A. (2015) Maintaining and monitoring the defined microbiota status of gnotobiotic rodents. ILAR J. 56, 241-249
13. Martin, F.-P., Dumas, M.-E., Wang, Y., Legido-Quigley, C., Yap, I. K., Tang, H., Zirah, S., Murphy, G. M., Cloarec, O., Lindon, J. C., Sprenger, N., Fay, L. B., Kochhar, S., van Bladeren, P., Holmes, E., and Nicholson, J. K. (2007) A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol. Syst. Biol. 3, 112
14. Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C., and Siuzdak, G. (2009) Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl. Acad. Sci. U.S.A. 106, 3698-3703
15. Claus, S. P., Tsang, T. M., Wang, Y., Cloarec, O., Skordi, E., Martin, F.-P., Rezzi, S., Ross, A., Kochhar, S., Holmes, E., and Nicholson, J. K. (2008) Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol. Syst. Biol. 4, 219
16. Matsumoto, M., Kibe, R., Ooga, T., Aiba, Y., Kurihara, S., Sawaki, E., Koga, Y., and Benno, Y. (2012) Impact of intestinal microbiota on intestinal luminal metabolome. Sci. Rep. 2, 233
17. Matsumoto, M., Kibe, R., Ooga, T., Aiba, Y., Sawaki, E., Koga, Y., and Benno, Y. (2013) Cerebral low-molecular metabolites influenced by intestinal microbiota: a pilot study. Front. Syst. Neurosci. 7, 9
18. Hicks, L. C., Huang, J., Kumar, S., Powles, S. T., Orchard, T. R., Hanna, G. B., and Williams, H. R. (2015) Analysis of exhaled breath volatile organic compounds in inflammatory bowel disease: a pilot study. J. Crohns Colitis 9, 731-737
19. Singhal, N., Kumar, M., Kanaujia, P. K., and Virdi, J. S. (2015) MALDITOF mass spectrometry: an emerging technology for microbial identification and diagnosis. Front. Microbiol. 6, 791
20. Stevenson, L. G., Drake, S. K., Shea, Y. R., Zelazny, A. M., and Murray, P. R. (2010) Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species. J. Clin. Microbiol. 48, 3482-3486
21. Seng, P., Abat, C., Rolain, J. M., Colson, P., Lagier, J.-C., Gouriet, F., Fournier, P. E., Drancourt, M., La Scola, B., and Raoult, D. (2013) Identification of rare pathogenic bacteria in a clinical microbiology laboratory: impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 51, 2182-2194
22. Samb-Ba, B., Mazenot, C., Gassama-Sow, A., Dubourg, G., Richet, H., Hugon, P., Lagier, J.-C., Raoult, D., and Fenollar, F. (2014) MALDI-TOF identification of the human gut microbiome in people with and without diarrhea in Senegal. PLoS ONE 9, e87419
23. Caspi, R., Foerster, H., Fulcher, C. A., Kaipa, P., Krummenacker, M., Latendresse, M., Paley, S., Rhee, S. Y., Shearer, A. G., Tissier, C., Walk, T. C., Zhang, P., and Karp, P. D. (2008) The MetaCyc Database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases. Nucleic Acids Res. 36, D623-D631
24. Wishart, D. S., Jewison, T., Guo, A. C., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., Bouatra, S., Sinelnikov, I., Arndt, D., Xia, J., Liu, P., et al. (2013) HMDB 3.0-The Human Metabolome Database in 2013. Nucleic Acids Res. 41, D801-D807
25. Wishart, D. S. (2007) Current progress in computational metabolomics. Brief Bioinform. 8, 279-293
26. Medema, M. H., and Fischbach, M. A. (2015) Computational approaches to natural product discovery. Nat. Chem. Biol. 11, 639-648
27. Hadjithomas, M., Chen, I.-M., Chu, K., Ratner, A., Palaniappan, K., Szeto, E., Huang, J., Reddy, T. B., Cimermančič, P., Fischbach, M. A., Ivanova, N. N., Markowitz, V. M., Kyrpides, N. C., and Pati, A. (2015) IMG-ABC: a knowledge base to fuel discovery of biosynthetic gene clusters and novel secondary metabolites. MBio. 6, e00932
28. Maurice, C. F., Haiser, H. J., and Turnbaugh, P. J. (2013) Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 152, 39-50
29. Haiser, H. J., Gootenberg, D. B., Chatman, K., Sirasani, G., Balskus, E. P., and Turnbaugh, P. J. (2013) Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 341, 295-298
30. Niehues, M., and Hensel, A. (2009) In vitro interaction of L-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinical differences in bioavailability? J. Pharm. Pharmacol. 61, 1303-1307
31. Carmody, R. N., and Turnbaugh, P. J. (2014) Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. J. Clin. Invest. 124, 4173-4181
32. McHardy, I. H., Goudarzi, M., Tong, M., Ruegger, P. M., Schwager, E., Weger, J. R., Graeber, T. G., Sonnenburg, J. L., Horvath, S., Huttenhower, C., McGovern, D. P., Fornace, A. J., Jr., Borneman, J., and Braun, J. (2013) Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships. Microbiome 1, 17
33. Mondot, S., and Lepage, P. (2016) The human gut microbiome and its dysfunctions through the meta-omics prism. Ann. N.Y. Acad. Sci. 1372, 9-19
34. Leone, V., Chang, E. B., and Devkota, S. (2013) Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases. J. Gastroenterol. 48, 315-321
35. Devkota, S., Wang, Y., Musch, M. W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., Antonopoulos, D. A., Jabri, B., and Chang, E. B. (2012) Dietaryfat- induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 487, 104-108
36. Marchesi, J. R., Holmes, E., Khan, F., Kochhar, S., Scanlan, P., Shanahan, F., Wilson, I. D., and Wang, Y. (2007) Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J. Proteome Res. 6, 546-551
37. Zhang, L. S., and Davies, S. S. (2016) Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med. 8, 46
38. Jansson, J., Willing, B., Lucio, M., Fekete, A., Dicksved, J., Halfvarson, J., Tysk, C., and Schmitt-Kopplin, P. (2009) Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS ONE 4, e6386
39. Nozaki, M., and Ishimura, Y. (1972) Tryptophan metabolism in microorganisms. Biochem. J. 128, 24P-25P
40. Bansal, T., Alaniz, R. C., Wood, T. K., and Jayaraman, A. (2010) The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proc. Natl. Acad. Sci. U.S.A. 107, 228-233
41. Shimada, Y., Kinoshita, M., Harada, K., Mizutani, M., Masahata, K., Kayama, H., and Takeda, K. (2013) Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon. PLoS ONE 8, e80604
42. Hubbard, T. D., Murray, I. A., Bisson, W. H., Lahoti, T. S., Gowda, K., Amin, S. G., Patterson, A. D., and Perdew, G. H. (2015) Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles. Sci. Rep. 5, 12689
43. Ji, T., Xu, C., Sun, L., Yu, M., Peng, K., Qiu, Y., Xiao, W., and Yang, H. (2015) Aryl hydrocarbon receptor activation down-regulates IL-7 and reduces inflammation in a mouse model of DSS-induced colitis. Dig. Dis. Sci. 60, 1958-1966
44. Lamas, B., Richard, M. L., Leducq, V., Pham, H.-P., Michel, M.-L., Da Costa, G., Bridonneau, C., Jegou, S., Hoffmann, T. W., Natividad, J. M., Brot, L., Taleb, S., Couturier-Maillard, A., Nion-Larmurier, I., Merabtene, F., et al. (2016) CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat. Med. 22, 598-605
45. Diaz Heijtz, R., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., Hibberd, M. L., Forssberg, H., and Pettersson, S. (2011) Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. U.S.A. 108, 3047-3052
46. Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., Korecka, A., Bakocevic, N., Ng, L. G., Guan, N. L., Kundu, P., Gulyás, B., Halldin, C., Hultenby, K., Nilsson, H., et al. (2014) The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 6, 263ra158
47. Rogers, G. B., Keating, D. J., Young, R. L., Wong, M.-L., Licinio, J., and Wesselingh, S. (2016) From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Mol. Psychiatry 21, 738-748
48. Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K. D., Verdu, E. F., and Collins, S. M. (2011) The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141, 599-609.e3
49. de Theije, C. G., Wopereis, H., Ramadan, M., van Eijndthoven, T., Lambert, J., Knol, J., Garssen, J., Kraneveld, A. D., and Oozeer, R. (2014) Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav. Immun. 37, 197-206
50. Gacias, M., Gaspari, S., Santos, P.-M., Tamburini, S., Andrade, M., Zhang, F., Shen, N., Tolstikov, V., Kiebish, M. A., Dupree, J. L., Zachariou, V., Clemente, J. C., and Casaccia, P. (2016) Microbiota-driven transcriptional changes in prefrontal cortex override genetic differences in social behavior. Elife 5, e13442
51. Rothhammer, V., Mascanfroni, I. D., Bunse, L., Takenaka, M. C., Kenison, J. E., Mayo, L., Chao, C.-C., Patel, B., Yan, R., Blain, M., Alvarez, J. I., Kebir, H., Anandasabapathy, N., Izquierdo, G., Jung, S., et al. (2016) Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 22, 586-597
52. Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., Dugar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., Wu, Y., Schauer, P., Smith, J. D., Allayee, H., Tang, W. H., et al. (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57-63
53. Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., Smith, J. D., DiDonato, J. A., Chen, J., Li, H., Wu, G. D., et al. (2013) Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 576-585
54. Feng, Q., Liu, Z., Zhong, S., Li, R., Xia, H., Jie, Z., Wen, B., Chen, X., Yan, W., Fan, Y., Guo, Z., Meng, N., Chen, J., Yu, X., Zhang, Z., et al. (2016) Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease. Sci. Rep. 6, 22525
55. Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., Mitchell, S. C., Holmes, E., McCarthy, M. I., Scott, J., Gauguier, D., and Nicholson, J. K. (2006) Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl. Acad. Sci. U.S.A. 103, 12511-12516
56. Miccheli, A., Capuani, G., Marini, F., Tomassini, A., Praticò, G., Ceccarelli, S., Gnani, D., Baviera, G., Alisi, A., Putignani, L., and Nobili, V. (2015) Urinary 1H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment. Int. J. Obes. 39, 1118-1125
57. Alisi, A., Bedogni, G., Baviera, G., Giorgio, V., Porro, E., Paris, C., Giammaria, P., Reali, L., Anania, F., and Nobili, V. (2014) Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis. Aliment. Pharmacol. Ther. 39, 1276-1285
58. Lukovac, S., Belzer, C., Pellis, L., Keijser, B. J., de Vos, W. M., Montijn, R. C., and Roeselers, G. (2014) Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. MBio 5, e01438